US Stock MarketDetailed Quotes

DMAC DiaMedica Therapeutics

Watchlist
  • 5.510
  • +0.080+1.47%
Close Jan 2 16:00 ET
235.61MMarket Cap-9.84P/E (TTM)

DiaMedica Therapeutics Key Stats

DiaMedica Therapeutics Q3 2024 Earnings Date

Currency:USDNov 13, 2024

Estimate
(YoY)
Actual
(YoY)
Vs Estimate
(% Chg)
EPS
-0.15
-0.15
+<0.01
Beat Est.
-29.19%
-25.00%
+3.16%
Net Income
--
-6.27M
--
-40.33%
Strong Buy

Oct 7, 2024

DiaMedica Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 2 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: CAD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 0.000--
--2024/Q4-- / 0.000--
Nov 13, 20242024/Q30.000 / 0.000--
Aug 7, 20242024/Q20.000 / 0.000--
May 8, 20242024/Q10.000 / 0.000--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 0.000--
--2024/Q4-- / 0.000--
Nov 13, 20242024/Q30.000 / 0.000--
Aug 7, 20242024/Q20.000 / 0.000--
May 8, 20242024/Q10.000 / 0.000--

Unlock Free Earnings Estimates

DiaMedica Therapeutics Earnings Reports

Read more

Trending US Stocks
Best Growth Stocks Best Growth Stocks

Spot stocks with huge growth potential and solid financial standing. Spot stocks with huge growth potential and solid financial standing.

Analysis

Analyst Rating

Updated: Oct 7, 2024

Strong Buy

  • Buy

    100.00%
  • Hold

    0.00%
  • Sell

    0.00%

Price Target

No Data